Flumedroxone acetate
Progestin; Progestogen ester | |
ATC code | ) |
---|---|
Identifiers | |
| |
JSmol) | |
| |
|
Flumedroxone acetate, sold under the brand names Demigran and Leomigran, is a
Medical uses
Flumedroxone acetate has been assessed in over 1,000 patients for the treatment of migraine, with effectiveness ranging from excellent to less than that of the reference antimigraine drug methysergide.[5] Other progestogens including medroxyprogesterone acetate, lynestrenol, allylestrenol, dydrogesterone, and normethandrone have also been found to be effective for migraine in a high percentage of women.[5]
Side effects
In accordance with its
Pharmacology
Pharmacodynamics
Flumedroxone acetate is said to have weak or slight progestogenic activity without other hormonal activity, including no estrogenic, antiestrogenic, androgenic, anabolic, or glucocorticoid activity.[5][1]
Chemistry
Flumedroxone acetate, also known as 6α-(trifluoromethyl)-17α-acetoxyprogesterone or as 6α-(trifluoromethyl)-17α-acetoxypregn-4-ene-3,20-dione, is a
History
Flumedroxone acetate was introduced for medical use in the 1960s.[4]
Society and culture
Generic names
Flumedroxone is the
Brand names
Flumedroxone acetate is or has been marketed under the brand names Demigran and Leomigran.[2][4]
Availability
Flumedroxone acetate is or has been marketed in Europe.[4]
See also
- Fluorometholone acetate
- Mometasone furoate
References
- ^ ISBN 978-3-13-589501-7.
Lundberg (1969) recommended the oral application of a steroid (flumedroxone) which has only a weak progesterone effect and does not display any other gonadotropic effects.
- ^ ISBN 978-1-4757-2085-3.
- ^ ISBN 978-0-470-28187-1.
- ^ PMID 6020856.
- ^ ISBN 978-3-642-88581-5.
- PMID 4877801.
- S2CID 9835328.